Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
BMC Pulmonary Medicine|March 6, 2022
Immune alveolitis in interstitial lung disease: an attractive cytological profile in immunocompromised patientsAntoine Moui, Stéphanie Dirou, Christine Sagan, et al.
Annales De Pathologie|March 25, 2018
[PD-L1 testing in non-small cell lung carcinoma: Guidelines from the PATTERN group of thoracic pathologists]Sylvie Lantuejoul, Julien Adam, Nicolas Girard, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 14, 2023
Deep Learning for Detecting BRCA Mutations in High-Grade Ovarian Cancer Based on an Innovative Tumor Segmentation Method From Whole Slide ImagesRaphaël Bourgade, Noémie Rabilloud, Tanguy Perennec, et al.
BMC Geriatrics|January 23, 2026
Transbronchial lung cryobiopsy: a safe and effective technique in the diagnosis of interstitial lung disease in the older peopleCharlotte Menigoz, Antoine Moui, Christine Sagan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 8, 2006
Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomographyCaroline Rousseau, Anne Devillers, Christine Sagan, et al.
Clinical Lung Cancer|October 26, 2019
Phase II Study Evaluating the Mechanisms of Resistance on Tumor Tissue and Liquid Biopsy in Patients With EGFR-mutated Non-pretreated Advanced Lung Cancer Receiving Osimertinib Until and Beyond Radiologic Progression: The MELROSE TrialJaafar Bennouna, Nicolas Girard, Clarisse Audigier-Valette, et al.
Annals of Intensive Care|June 11, 2025
Post-mortem lung biopsies in fatal Covid-19 acute respiratory distress syndrome: a prospective cohort study of 169 patients (HISTOCOVID)Jean Morin, Christine Sagan, Morgane Pere, et al.
Cancer Research Communications|June 28, 2023
Dissecting the Origin of Heterogeneity in Uterine and Ovarian CarcinosarcomasAnne-Sophie Sertier, Anthony Ferrari, Roxane M Pommier, et al.
Annales De Pathologie|November 9, 2010
[Update of the GEFPICS' recommendations for HER2 status determination in breast cancers in France]Frédérique Penault-Llorca, Anne Vincent-Salomon, Jean-Pierre Bellocq, et al.
Annales De Pathologie|December 3, 2014
[Pre-analytical stage for biomarker assessment in breast cancer: 2014 update of the GEFPICS' guidelines in France]Gaëtan MacGrogan, Marie-Christine Mathieu, Bruno Poulet, et al.
Pageof 5